<p>CeriBell, Inc.（纳斯达克代码：CBLL - 获取免费报告）首席执行官 Xingjuan Chao 于 4 月 6 日星期一出售了 39,000 股 CeriBell 股票。该股票的平均售价为 18.40 美元，总价值为 717,600.00 美元。交易后，首席执行官持有公司 850,347 股股票，价值为 15,646,384.80 美元。此次交易使其持股减少了 4.39%。该交易已在向 SEC 提交的文件中披露，具体内容可通过此链接查看。该交易是在预先安排的 10b5-1 交易计划下执行的。</p>
<p>Xingjuan Chao 最近还进行了以下交易：</p>
<ul>
<li>在 3 月 3 日星期二，Xingjuan Chao 出售了 39,000 股 CeriBell 股票。该股票的平均售价为 17.45 美元，总价值为 680,550.00 美元。</li>
<li>在 2 月 23 日星期一，Xingjuan Chao 出售了 2,084 股 CeriBell 股票。该股票的平均售价为 19.79 美元，总价值为 41,242.36 美元。</li>
</ul>
<h2>CeriBell 股票表现</h2>
<p>在周三的午盘交易中，CBLL 股票上涨了 0.78 美元，达到了 18.65 美元。该公司交易了 106,877 股，相较于其平均交易量 326,328 股。该公司的 50 日简单移动平均为 19.15 美元，200 日简单移动平均为 17.57 美元。公司的流动比率为 9.73，速动比率为 9.35，债务股本比率为 0.13。该股票的市值为 7.0185 亿美元，市盈率为-12.75，贝塔值为 0.94。CeriBell, Inc.的 1 年最低价为 10.01 美元，1 年最高价为 24.33 美元。</p>
<p>CeriBell（纳斯达克代码：CBLL - 获取免费报告）最近于 2 月 24 日星期二发布了季度财报。公司报告每股收益（EPS）为-0.36 美元，超出市场共识预期的-0.43 美元，差额为 0.07 美元。CeriBell 的净利润率为-59.97%，股本回报率为-31.77%。该公司在本季度的收入为 2478 万美元，而市场共识预期为 2395 万美元。分析师平均预测 CeriBell, Inc.在当前年度的每股收益为-2.46 美元。</p>
<h2>CeriBell 的机构交易</h2>
<p>机构投资者最近买入和卖出了该公司的股票。Caitong International Asset Management Co. Ltd 在第四季度将其在 CeriBell 的持股增加了 3971.0%。Caitong International Asset Management Co. Ltd 现在拥有 1262 股公司股票，价值 28,000 美元，此前在该期间内又购买了 1231 股。CWM LLC 在第四季度将其在 CeriBell 的持股增加了 1178.5%。CWM LLC 现在拥有 1841 股公司股票，价值 40,000 美元，此前在该期间内又购买了 1697 股。Tower Research Capital LLC TRC 在第二季度将其在 CeriBell 的持股增加了 353.8%。Tower Research Capital LLC TRC 现在拥有 2310 股公司股票，价值 43,000 美元，此前在该期间内又购买了 1801 股。Larson Financial Group LLC 在第四季度将其在 CeriBell 的持股增加了 1403.1%。Larson Financial Group LLC 现在拥有 2871 股公司股票，价值 63,000 美元，此前在该期间内又购买了 2680 股。最后，Zurcher Kantonalbank Zurich Cantonalbank 在第三季度获得了 CeriBell 的新头寸，价值约 33,000 美元。</p>
<h2>华尔街分析师预测增长</h2>
<p>多家研究公司对 CBLL 进行了评估。Canaccord Genuity Group 在 12 月 17 日的研究报告中将 CeriBell 的目标价格从 29.00 美元上调至 30.00 美元，并给予该股票 “买入” 评级。Weiss Ratings 在周一的研究报告中重申了对 CeriBell 的 “卖出（d-）” 评级。TD Cowen 在 12 月 9 日的研究报告中重申了对 CeriBell 的 “买入” 评级。最后，BTIG Research 在 1 月 28 日的研究报告中重申了对 CeriBell 的 “买入” 评级，并设定了 30.00 美元的目标价格。一位研究分析师给予该股票 “强烈买入” 评级，四位分析师给予 “买入” 评级，一位分析师给予 “卖出” 评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，平均目标价格为 23.20 美元。</p>
<p><strong>阅读我们关于 CeriBell 的最新股票报告</strong></p>
<h2>CeriBell 公司简介</h2>
<p>（获取免费报告）</p>
<p>CeriBell Corp 纳斯达克：CBLL 是一家医疗科技公司，专注于自动化新生儿听力筛查设备的设计、制造和销售。该公司提供一系列基于耳声发射（OAE）和听觉脑干反应（ABR）技术的医疗诊断工具，能够早期检测婴儿的听力障碍。CeriBell 的解决方案被用于医院、分娩中心和听力学诊所，以支持旨在通过及时干预改善语言发展结果的普遍新生儿听力筛查项目。</p>
<p>该公司的产品组合包括手持和桌面筛查设备、用于数据管理的专有软件以及旨在简化测试工作流程的配件。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票，胜过 CeriBell</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0JMTA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0JMTA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 CeriBell 吗？</h2>
<p>在考虑 CeriBell 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 CeriBell 并不在名单上。</p>
<p>虽然 CeriBell 目前在分析师中被评为适度买入，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

CBLL

<p>CeriBell, Inc. 首席执行官赵星娟以平均价格 18.40 美元出售了 39,000 股公司股票，总计 717,600 美元。这次出售使赵的持股减少了 4.39%，剩余 850,347 股，估值约为 1565 万美元。该交易是在 10b5-1 交易计划下进行，并已向美国证券交易委员会（SEC）披露。CeriBell 的股票最近交易价格为 18.65 美元，市值为 7.0185 亿美元，市盈率为-12.75。分析师对该股票的评级不一，普遍评级为 “适度买入”，平均目标价格为 23.20 美元</p>

<p>CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) CEO Xingjuan Chao sold 39,000 shares of CeriBell stock in a transaction dated Monday, April 6th. The stock was sold at an average price of $18.40, for a total value of $717,600.00. Following the transaction, the chief executive officer owned 850,347 shares of the company's stock, valued at $15,646,384.80. The trade was a 4.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.</p>
<div class="lb-trans"><p>CeriBell, Inc.（纳斯达克代码：CBLL - 获取免费报告）首席执行官 Xingjuan Chao 于 4 月 6 日星期一出售了 39,000 股 CeriBell 股票。该股票的平均售价为 18.40 美元，总价值为 717,600.00 美元。交易后，首席执行官持有公司 850,347 股股票，价值为 15,646,384.80 美元。此次交易使其持股减少了 4.39%。该交易已在向 SEC 提交的文件中披露，具体内容可通过此链接查看。该交易是在预先安排的 10b5-1 交易计划下执行的。</p>
</div><p>Xingjuan Chao also recently made the following trade(s):</p>
<div class="lb-trans"><p>Xingjuan Chao 最近还进行了以下交易：</p>
</div><ul>
<li>On Tuesday, March 3rd, Xingjuan Chao sold 39,000 shares of CeriBell stock. The stock was sold at an average price of $17.45, for a total value of $680,550.00.</li>
<li>On Monday, February 23rd, Xingjuan Chao sold 2,084 shares of CeriBell stock. The stock was sold at an average price of $19.79, for a total value of $41,242.36.</li>
</ul>
<div class="lb-trans"><ul>
<li>在 3 月 3 日星期二，Xingjuan Chao 出售了 39,000 股 CeriBell 股票。该股票的平均售价为 17.45 美元，总价值为 680,550.00 美元。</li>
<li>在 2 月 23 日星期一，Xingjuan Chao 出售了 2,084 股 CeriBell 股票。该股票的平均售价为 19.79 美元，总价值为 41,242.36 美元。</li>
</ul>
</div><h2>CeriBell Stock Performance</h2>
<div class="lb-trans"><h2>CeriBell 股票表现</h2>
</div><p>CBLL stock traded up $0.78 during mid-day trading on Wednesday, hitting $18.65. 106,877 shares of the company were exchanged, compared to its average volume of 326,328. The business has a 50 day simple moving average of $19.15 and a 200-day simple moving average of $17.57. The company has a current ratio of 9.73, a quick ratio of 9.35 and a debt-to-equity ratio of 0.13. The stock has a market capitalization of $701.85 million, a PE ratio of -12.75 and a beta of 0.94. CeriBell, Inc. has a 1-year low of $10.01 and a 1-year high of $24.33.</p>
<div class="lb-trans"><p>在周三的午盘交易中，CBLL 股票上涨了 0.78 美元，达到了 18.65 美元。该公司交易了 106,877 股，相较于其平均交易量 326,328 股。该公司的 50 日简单移动平均为 19.15 美元，200 日简单移动平均为 17.57 美元。公司的流动比率为 9.73，速动比率为 9.35，债务股本比率为 0.13。该股票的市值为 7.0185 亿美元，市盈率为-12.75，贝塔值为 0.94。CeriBell, Inc.的 1 年最低价为 10.01 美元，1 年最高价为 24.33 美元。</p>
</div><p>CeriBell (NASDAQ:CBLL - Get Free Report) last issued its quarterly earnings data on Tuesday, February 24th. The company reported ($0.36) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.07. CeriBell had a negative net margin of 59.97% and a negative return on equity of 31.77%. The firm had revenue of $24.78 million during the quarter, compared to the consensus estimate of $23.95 million. On average, equities analysts forecast that CeriBell, Inc. will post -2.46 earnings per share for the current year.</p>
<div class="lb-trans"><p>CeriBell（纳斯达克代码：CBLL - 获取免费报告）最近于 2 月 24 日星期二发布了季度财报。公司报告每股收益（EPS）为-0.36 美元，超出市场共识预期的-0.43 美元，差额为 0.07 美元。CeriBell 的净利润率为-59.97%，股本回报率为-31.77%。该公司在本季度的收入为 2478 万美元，而市场共识预期为 2395 万美元。分析师平均预测 CeriBell, Inc.在当前年度的每股收益为-2.46 美元。</p>
</div><h2>Institutional Trading of CeriBell</h2>
<div class="lb-trans"><h2>CeriBell 的机构交易</h2>
</div><p>Institutional investors have recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd raised its holdings in shares of CeriBell by 3,971.0% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,262 shares of the company's stock valued at $28,000 after purchasing an additional 1,231 shares during the period. CWM LLC raised its holdings in shares of CeriBell by 1,178.5% during the fourth quarter. CWM LLC now owns 1,841 shares of the company's stock valued at $40,000 after purchasing an additional 1,697 shares during the period. Tower Research Capital LLC TRC raised its holdings in shares of CeriBell by 353.8% during the second quarter. Tower Research Capital LLC TRC now owns 2,310 shares of the company's stock valued at $43,000 after purchasing an additional 1,801 shares during the period. Larson Financial Group LLC raised its holdings in shares of CeriBell by 1,403.1% during the fourth quarter. Larson Financial Group LLC now owns 2,871 shares of the company's stock valued at $63,000 after purchasing an additional 2,680 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in shares of CeriBell during the third quarter valued at about $33,000.</p>
<div class="lb-trans"><p>机构投资者最近买入和卖出了该公司的股票。Caitong International Asset Management Co. Ltd 在第四季度将其在 CeriBell 的持股增加了 3971.0%。Caitong International Asset Management Co. Ltd 现在拥有 1262 股公司股票，价值 28,000 美元，此前在该期间内又购买了 1231 股。CWM LLC 在第四季度将其在 CeriBell 的持股增加了 1178.5%。CWM LLC 现在拥有 1841 股公司股票，价值 40,000 美元，此前在该期间内又购买了 1697 股。Tower Research Capital LLC TRC 在第二季度将其在 CeriBell 的持股增加了 353.8%。Tower Research Capital LLC TRC 现在拥有 2310 股公司股票，价值 43,000 美元，此前在该期间内又购买了 1801 股。Larson Financial Group LLC 在第四季度将其在 CeriBell 的持股增加了 1403.1%。Larson Financial Group LLC 现在拥有 2871 股公司股票，价值 63,000 美元，此前在该期间内又购买了 2680 股。最后，Zurcher Kantonalbank Zurich Cantonalbank 在第三季度获得了 CeriBell 的新头寸，价值约 33,000 美元。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>A number of research firms have weighed in on CBLL. Canaccord Genuity Group boosted their target price on shares of CeriBell from $29.00 to $30.00 and gave the stock a &#34;buy&#34; rating in a research note on Wednesday, December 17th. Weiss Ratings reaffirmed a &#34;sell (d-)&#34; rating on shares of CeriBell in a research note on Monday. TD Cowen reaffirmed a &#34;buy&#34; rating on shares of CeriBell in a research note on Tuesday, December 9th. Finally, BTIG Research reaffirmed a &#34;buy&#34; rating and set a $30.00 target price on shares of CeriBell in a research note on Wednesday, January 28th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $23.20.</p>
<div class="lb-trans"><p>多家研究公司对 CBLL 进行了评估。Canaccord Genuity Group 在 12 月 17 日的研究报告中将 CeriBell 的目标价格从 29.00 美元上调至 30.00 美元，并给予该股票 “买入” 评级。Weiss Ratings 在周一的研究报告中重申了对 CeriBell 的 “卖出（d-）” 评级。TD Cowen 在 12 月 9 日的研究报告中重申了对 CeriBell 的 “买入” 评级。最后，BTIG Research 在 1 月 28 日的研究报告中重申了对 CeriBell 的 “买入” 评级，并设定了 30.00 美元的目标价格。一位研究分析师给予该股票 “强烈买入” 评级，四位分析师给予 “买入” 评级，一位分析师给予 “卖出” 评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，平均目标价格为 23.20 美元。</p>
</div><p><strong>Read Our Latest Stock Report on CeriBell</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 CeriBell 的最新股票报告</strong></p>
</div><h2>CeriBell Company Profile</h2>
<div class="lb-trans"><h2>CeriBell 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>CeriBell Corp NASDAQ: CBLL is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell's solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.</p>
<div class="lb-trans"><p>CeriBell Corp 纳斯达克：CBLL 是一家医疗科技公司，专注于自动化新生儿听力筛查设备的设计、制造和销售。该公司提供一系列基于耳声发射（OAE）和听觉脑干反应（ABR）技术的医疗诊断工具，能够早期检测婴儿的听力障碍。CeriBell 的解决方案被用于医院、分娩中心和听力学诊所，以支持旨在通过及时干预改善语言发展结果的普遍新生儿听力筛查项目。</p>
</div><p>The company's product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.</p>
<div class="lb-trans"><p>该公司的产品组合包括手持和桌面筛查设备、用于数据管理的专有软件以及旨在简化测试工作流程的配件。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than CeriBell</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 CeriBell</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0JMTA" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NASDAQ&amp;Symbol=CBLL"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CeriBell Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 CeriBell 吗？</h2>
</div><p>Before you consider CeriBell, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 CeriBell 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CeriBell wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 CeriBell 并不在名单上。</p>
</div><p>While CeriBell currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CeriBell 目前在分析师中被评为适度买入，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Xingjuan Chao 出售 39,000 股 Ceribell（NASDAQ:CBLL）股票